05.06.2024 15:06:09 - dpa-AFX: *AMGEN'S UPLIZNA SHOWS PROMISE IN PHASE 3 TRIAL FOR IMMUNOGLOBULIN G4-RELATED DISEASE

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Amgen 867900 NASDAQ 330,400 19.07.24 19:46:35 -0,570 -0,17% 330,220 330,520 333,650 330,970

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH